(2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[7-methyl-4-[4-(trifluoromethyl)cyclohexyl]pyrido[2,3-d]pyrimidin-2-yl]morpholine;4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-2-(1-methylpyrazol-4-yl)morpholine;ethane
C50H57F5N12O2 — CID 157044519
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[7-methyl-4-[4-(trifluoromethyl)cyclohexyl]pyrido[2,3-d]pyrimidin-2-yl]morpholine;4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-2-(1-methylpyrazol-4-yl)morpholine;ethane
(2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[7-methyl-4-[4-(trifluoromethyl)cyclohexyl]pyrido[2,3-d]pyrimidin-2-yl]morpholine;4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-2-(1-methylpyrazol-4-yl)morpholine;ethane (PubChem CID 157044519) has the molecular formula C50H57F5N12O2 and a molecular weight of 953.08 g/mol. Its IUPAC name is (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[7-methyl-4-[4-(trifluoromethyl)cyclohexyl]pyrido[2,3-d]pyrimidin-2-yl]morpholine;4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-2-(1-methylpyrazol-4-yl)morpholine;ethane.
Molecular Properties
| Compound Name | (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[7-methyl-4-[4-(trifluoromethyl)cyclohexyl]pyrido[2,3-d]pyrimidin-2-yl]morpholine;4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-2-(1-methylpyrazol-4-yl)morpholine;ethane |
|---|---|
| PubChem CID | 157044519 |
| Molecular Formula | C50H57F5N12O2 |
| Molecular Weight | 953.08 g/mol |
| Exact Mass | 952.46 |
| IUPAC Name | (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[7-methyl-4-[4-(trifluoromethyl)cyclohexyl]pyrido[2,3-d]pyrimidin-2-yl]morpholine;4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-2-(1-methylpyrazol-4-yl)morpholine;ethane |
| SMILES | CC.Cc1cc2c(-c3ccc(F)cc3F)nc(N3CCOC(c4cnn(C)c4)C3)nc2nc1C.Cc1ccc2c(C3CCC(C(F)(F)F)CC3)nc(N3CCO[C@H](c4cnn(C5CC5)c4)C3)nc2n1 |
| InChI | InChI=1S/C25H29F3N6O.C23H22F2N6O.C2H6/c1-15-2-9-20-22(16-3-5-18(6-4-16)25(26,27)28)31-24(32-23(20)30-15)33-10-11-35-21(14-33)17-12-29-34(13-17)19-7-8-19;1-13-8-18-21(17-5-4-16(24)9-19(17)25)28-23(29-22(18)27-14(13)2)31-6-7-32-20(12-31)15-10-26-30(3)11-15;1-2/h2,9,12-13,16,18-19,21H,3-8,10-11,14H2,1H3;4-5,8-11,20H,6-7,12H2,1-3H3;1-2H3/t16?,18?,21-;;/m0../s1 |
| InChIKey | LAZOGNSGJLRXLE-FFBVWINISA-N |
| XLogP | 10.20 |
| TPSA | 137.92 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 953.08 |
| LogP ≤ 5 | 10.20 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157044519 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.